About AxoSim
AxoSim is a company based in New Orleans (United States) founded in 2014. AxoSim has raised $6.78 million across 11 funding rounds from investors including NIH, TPG and HHS. The company has 27 employees as of December 31, 2022. AxoSim offers products and services including AxoSim Platform and Products. AxoSim operates in a competitive market with competitors including Emulate, CN Bio, Mimetas, Nortis and NETRI, among others.
- Headquarter New Orleans, United States
- Employees 27 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Axosim, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.78 M (USD)
in 11 rounds
-
Latest Funding Round
$3.68 M (USD), Series A
Nov 08, 2024
-
Investors
NIH
& 6 more
-
Employee Count
27
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AxoSim
AxoSim offers a comprehensive portfolio of products and services, including AxoSim Platform and Products.
Tool for building and studying human brain models in labs.
Resources for addressing neurological disorders through lab innovation.
People of AxoSim
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of AxoSim
AxoSim has successfully raised a total of $6.78M across 11 strategic funding rounds. The most recent funding activity was a Series A round of $3.68 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AxoSim
AxoSim has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, TPG and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Jefferson Capital Partners is engaged in providing growth capital solutions.
|
Locked | Locked | Locked | |
|
A 4-month acceleration program for technology startups is provided.
|
Locked | Locked | Locked | |
|
Fund of funds focused on pre-seed and seed-stage companies
|
Locked | Locked | Locked |
Investor details for AxoSim
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AxoSim
Investment portfolio details for AxoSim
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AxoSim
Detailed financials for AxoSim
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Axosim Comparisons
Peer comparison for AxoSim
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AxoSim
AxoSim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, Mimetas, Nortis and NETRI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of in vitro models for drug development
|
|
| Locked | Locked | Locked |
Organ-on-a-chip platforms are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Microfluidics-based organ-on-a-chip models for drug evaluation are developed.
|
|
| Locked | Locked | Locked |
Small human tissue segments are generated in microfluidic chips.
|
|
| Locked | Locked | Locked |
Microfluidic devices are developed for industrial applications and brain-on-a-chip models.
|
Detailed competitors of AxoSim
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Axosim
Complete news archive for AxoSim
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AxoSim
AxoSim was founded in 2014 and raised its 1st funding round 2 years after it was founded.
AxoSim is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
AxoSim is a funded company, having raised a total of $6.78M across 11 funding rounds to date.
As of Dec 31, 2022, the latest employee count at AxoSim is 27.
AxoSim was founded in 2014 in New Orleans, United States, with a focus on biotechnology. Nerve-on-a-chip technology, a 3D cell-based model mimicking nerve functions, was developed in Dr. Michael J. Moores lab at Tulane University. Funding has been received from the National Science Foundations Innovation Corps program. Operations center on creating these models to support drug testing and development processes in the biotech sector.
AxoSim's top competitors include Emulate, CN Bio and Cellbox Labs.
AxoSim offers AxoSim Platform and Products.
AxoSim has 7 investors. Key investors include NIH, TPG, HHS, The Idea Village, and Benson Capital Partners.